# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001213900-26-081390
Filing Date
2026-07-24
Accepted
2026-07-24 16:16:57
Documents
17
Period of Report
2026-09-09

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | PROXY STATEMENT | ea0298814-01.htm iXBRL | DEF 14A | 920949
2 | GRAPHIC | tos_logo.jpg | GRAPHIC | 84536
3 | GRAPHIC | tos_logo1.jpg | GRAPHIC | 84547
4 | GRAPHIC | tproxy_001.jpg | GRAPHIC | 1176788
5 | GRAPHIC | tproxy_002.jpg | GRAPHIC | 1328253
| Complete submission text file | 0001213900-26-081390.txt |  | 7669846

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL SCHEMA FILE | ostx-20251231.xsd | EX-101.SCH | 1436
7 | XBRL LABEL FILE | ostx-20251231_lab.xml | EX-101.LAB | 439
20 | EXTRACTED XBRL INSTANCE DOCUMENT | ea0298814-01_htm.xml | XML | 5844

Mailing Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850
Business Address 15825 SHADY GROVE ROAD SUITE 135 ROCKVILLE MD 20850 410-297-7793
OS Therapies Inc (Filer) CIK: 0001795091 (see all company filings)

EIN.: 825118368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-42195 | Film No.: 261201696
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)